Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca

NCT00128245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca

Interventions

DRUG: Pimecrolimus
DRUG: Vehicle

Sponsor

Novartis